Clinically significant anemia in HIV-infected pregnant women in India is not a major barrier to zidovudine use for prevention of maternal-to-child transmission

Journal of Acquired Immune Deficiency Syndromes

Volumn 45, Issue 2, 2007, Pages 210-217

  Sinha, Gita ^a   Choi, Tou J ^a   Nayak, Uma ^a   Gupta, Amita ^a   Nair, Sandeep ^b   Gupte, Nikhil ^c   Bulakh, Pandurang M ^b   Sastry, Jayagowri ^c   Deshmukh, Sanjay D ^d   Khandekar, Medha M ^b   Kulkarni, Vandana ^c   Bhosale, Ramesh A ^b   Bharucha, Kapila E ^e   Phadke, Mrudula A ^f   Kshirsagar, Anandini S ^g   Bollinger, Robert C ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Byramjee Jejeebhoy Medical College   (India)

^c EDS   (India)

^d Kolhapur Medical College   (India)

^e Institute of Health Management Pachod   (India)

^f MAHARASHTRA UNIVERSITY OF HEALTH SCIENCES   (India)

^g Modern College   (India)

Author keywords

Anemia; HIV; India; Pregnancy; Prevention of maternal to child transmission; Zidovudine

Indexed keywords

AUTRIN; CYANOCOBALAMIN; FERROUS FUMARATE; FOLIC ACID; HEMOGLOBIN; IRON; NEVIRAPINE; UNCLASSIFIED DRUG; ZIDOVUDINE;

ADULT; ADVERSE OUTCOME; ANEMIA; ARTICLE; BIRTH WEIGHT; CD4 LYMPHOCYTE COUNT; CHEMOPROPHYLAXIS; CLINICAL ASSESSMENT; COMBINATION CHEMOTHERAPY; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG USE; FEMALE; FETUS OUTCOME; GESTATIONAL AGE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; IRON THERAPY; MAJOR CLINICAL STUDY; MONOTHERAPY; PREGNANT WOMAN; PREMATURE LABOR; PRENATAL CARE; PRIORITY JOURNAL; RISK ASSESSMENT; SCREENING; SIDE EFFECT; SINGLE DRUG DOSE; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; VERTICAL TRANSMISSION; VITAMIN SUPPLEMENTATION;

ADULT; ANEMIA; DISEASE TRANSMISSION, VERTICAL; FEMALE; FOLIC ACID; HIV INFECTIONS; HUMANS; INDIA; IRON; PREGNANCY; ZIDOVUDINE;

EID: 34249896697     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3180556000     Document Type: Article

References (31)

1. Ramachandran P. Maternal nutrition - effect on fetal growth and outcome of pregnancy. Nutr Rev. 2002;60(Suppl):S26-S35.
2. Cunningham FG, Hauth JC, Leveno KJ, et al. Anemias. In: Williams' Obstetrics. New York: McGraw Hill; 2005:1143-1169.
3. Centers for Disease Control and Prevention. Progress in chronic disease prevention anemia during pregnancy in low-income women - United States, 1987. MMWR Morb Mortal Wkly Rep. 1990;39:73-76, 81.
4. Klebanoff MA, Shiono PH, Selby JV, et al. Anemia and spontaneous preterm birth. Am J Obstet Gynecol. 1991;164:59-63.
5. Scholl TO, Hediger ML. Anemia and iron-deficiency anemia: compilation of data on pregnancy outcome. Am J Clin Nutr. 1994;59(Suppl):492S-500S.
6. Yip R. Significance of abnormally low or high hemoglobin concentration during pregnancy: special consideration of iron nutrition. Am J Clin Nutr. 2000;72(Suppl):272S-279S.
7. Sifakis S, Pharmakides G. Anemia in pregnancy. Ann NY Acad Sci. 2000;900:125-136.
8. Belperio PS, Rhew DC. Prevalence and outcomes of anemia in individuals with human immunodeficiency virus: a systematic review of the literature. Am J Med. 2004;116(Suppl 7A):27S-43S.
9. Antelman G, Msamanga GI, Speigelman D, et al. Nutritional factors and infectious disease contribute to anemia among pregnant women with human immunodeficiency virus in Tanzania. J Nutr. 2000;130:1950-1957.
10. Meda N, Dao B, Ouangre A. HIV, maternal anemia and perinatal intervention using zidovudine. DITRAME Study Group (ANRS 049 Clinical Trial). Int J Gynaecol Obstet. 1998;61:65-66.
11. Ramon R, Sawadogo D, Koko FS, et al. Haematological characteristics and HIV status of pregnant women in Abidjan, Cote d'Ivoire, 1995-1996. Trans R Soc Trop Med Hyg. 1999;93:419-422.
12. Mehta SH, Gupta A, Sahay S, et al. High HIV prevalence among a high-risk subgroup of women attending sexually transmitted infection clinics in Pune, India. J Acquir Immune Defic Syndr. 2006;41:75-80.
13. Bharucha KE, Sastry J, Shrotri A, et al. Feasibility of voluntary counseling and testing services for HIV among pregnant women presenting in labour in Pune, India. Int J STD AIDS. 2005;16:553-555.
14. World Health Organization, Department of HIV/AIDS. Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants. Geneva, Switzerland: WHO; 2004.
15. Gupta SB, Pujari SN, Joshi SR, et al, for Expert Panel of Guidelines Development Committee. API consensus guidelines for use of anti-retroviral therapy in adults (API-ART guidelines). J Assoc Physicians India. 2006;54:57-74.
16. Richman DD, Fischl MA, Grieco MH, et al. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med. 1987;317:192-197.
17. Conly ATJ, Fletcher D, Keystone D, et al. Precipitous declines in hemoglobin levels associated with combination zidovudine and lamivudine therapy. Clin Infect Dis. 1998;27:908-909.
18. Kanshana S, Thewanda D, Teeraratkul A, et al. Implementing short-course zidovudine to reduce mother-infant HIV transmission in a large pilot program in Thailand. AIDS. 2000;14:1617-1623.
19. Centers for Disease Control and Prevention. Evaluation of a regional pilot program to prevent mother-infant HIV transmission - Thailand, 1998-2000. MMWR Morb Mortal Wkly Rep. 2001;50:599-603.
20. Bhore AV, Sastry J, Patke D, et al. Sensitivity and specificity of rapid HIV testing of pregnant women in India. Int J STD AIDS. 2003;14:37-41.
21. Stoltzfus RJ, Dreyfuss ML. Guidelines for pregnant women. In: Guidelines for Use of Iron Supplementation to Prevent and Treat Iron Deficiency Anemia. Washington, DC: International Nutritional Anemia Consultative Group; 1998:19-21.
22. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med. 1994;331:1173-1180.
23. Sperling RS, Shapiro DE, McSherry GD, et al. Safety of the maternalinfant zidovudine regimen utilized in the PACTG 076 Study. AIDS. 1998;12:1805-1813.
24. Meda N, Mandelbrot L, Cartoux M, et al. Anaemia during pregnancy in Burkina Faso,West Africa, 1995-1996: prevalence and associated factors. DITRAME Study Group. Bull World Health Organ. 1999;77:916-922.
25. Dabis F, Msellati P, Meda N, et al. 6-Month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Cote d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. DITRAME Study Group. Diminution de la Transmission Mere-Enfant. Lancet. 1999;353:786-792.
26. Wiktor SZ, Ekpini E, Karon JM, et al. Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Cote d'Ivoire: a randomized trial. Lancet. 1999;353:781-785.
27. Shaffer N, Chuachoowong R, Mock PA, et al. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomized controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group. Lancet. 1999;353:773-780.
28. Chaisilwattana P, Chekephaibulkit K, Chalerunchockchroenkit A, et al. Short-course therapy with zidovudine and lamivudine for prevention of maternal to child transmission of HIV in Thailand. Clin Infect Dis. 2002;35:1406-1413.
29. Mandelbrot L, Landreau-Mascara A, Rekacewicz C, et al. Lamivudinezidovudine combination for prevention of maternal to child transmission of HIV-1. JAMA. 2001;285:2083-2093.
30. Lambert JS, Noguiera SA, Abreu T, et al. A pilot study to evaluate the safety and feasibility of administration of AZT/3TC fixed dose combination to HIV-infected pregnant women and their infants in Rio de Janeiro, Brazil. Sex Transm Infect. 2003;79:448-452.
31. National AIDS Control Organization, Government of India. NACO PMTCT guidelines. Available at: www.nacoonline.org. Accessed February 10, 2007.